These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30691940)

  • 21. Predictive factors for failure of the levonorgestrel releasing intrauterine system in women with heavy menstrual bleeding.
    Beelen P; van den Brink MJ; Herman MC; Geomini PM; Duijnhoven RG; Bongers MY
    BMC Womens Health; 2021 Feb; 21(1):57. PubMed ID: 33563257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy.
    Caruso S; Cianci S; Vitale SG; Fava V; Cutello S; Cianci A
    Eur J Contracept Reprod Health Care; 2018 Feb; 23(1):24-31. PubMed ID: 29436865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire.
    Radesic B; Sharma A
    Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):247-51. PubMed ID: 15191451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of insertion of levonorgestrel-releasing intrauterine system: a randomised controlled trial.
    van der Heijden P; Geomini P; Herman MC; Veersema S; Bongers MY
    BJOG; 2017 Jan; 124(2):299-305. PubMed ID: 28012273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting menstrual bleeding patterns with levonorgestrel-releasing intrauterine systems.
    Frenz AK; Ahlers C; Beckert V; Gerlinger C; Friede T
    Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):48-57. PubMed ID: 33269954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
    Abou-Setta AM; Al-Inany HG; Farquhar CM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities.
    Savasi I; Jayasinghe K; Moore P; Jayasinghe Y; Grover SR
    J Pediatr Adolesc Gynecol; 2014 Feb; 27(1):25-8. PubMed ID: 24315712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study.
    Bastianelli C; Farris M; Rosato E; Varliero F; Del Savio MC; Facchinetti F; Grandi G
    Eur J Contracept Reprod Health Care; 2022 Feb; 27(1):16-22. PubMed ID: 34528867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system.
    Gemzell-Danielsson K; Inki P; Heikinheimo O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1177-88. PubMed ID: 21854367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.
    Hillard PJ
    J Pediatr Adolesc Gynecol; 2012 Oct; 25(5):308-13. PubMed ID: 22831901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).
    Heikinheimo O; Gemzell-Danielsson K
    Acta Obstet Gynecol Scand; 2012 Jan; 91(1):3-9. PubMed ID: 22007693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of early vs. delayed postpartum insertion of the LNG-IUS on breastfeeding continuation: a systematic review and meta-analysis of randomised controlled trials.
    Abdelhakim AM; Sunoqrot M; Amin AH; Nabil H; Raslan AN; Samy A
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):327-336. PubMed ID: 31517549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.